n-Butyrate Concentration Test

The concentration of n-butyrate (butyric acid) in stool provides a functional snapshot of gut microbial activity and intestinal health. n-Butyrate is one of the three main short-chain fatty acids (SCFAs) generated when gut bacteria ferment dietary fibers. It serves as a critical energy source for the cells lining your colon, supports immune balance, and has systemic effects on metabolism and blood pressure. Measuring fecal n-butyrate concentration captures how well these microbial and host processes are working together.

Dietary fiber is the dominant determinant of n-butyrate concentration. Resistant starches and fermentable fibers from foods such as oats, legumes, and cooked-and-cooled potatoes can substantially raise fecal butyrate, but responses differ widely between individuals. This variability stems from differences in the abundance of butyrate-producing bacteria, including Faecalibacterium prausnitzii, Eubacterium rectale, and Roseburia species. A diverse microbiome enriched with these species generally maintains stable butyrate levels even under dietary fluctuation.

Gut transit time also modifies fecal concentration. Faster transit, whether from fiber, magnesium, or osmotic laxatives, tends to increase fecal n-butyrate by reducing the time for absorption, whereas slower transit allows colonocytes to consume more butyrate, lowering fecal levels. Thus, both extremely low and extremely high concentrations can indicate imbalances: low levels may reflect reduced microbial fermentation or inflammation, while very high levels can occur with rapid transit or microbial overproduction.

n-Butyrate concentration has been linked to several health outcomes. Higher fecal and circulating levels are associated with lower blood pressure and reduced cardiovascular risk, likely due to butyrate’s anti-inflammatory and vasodilatory properties. Conversely, reduced concentrations are seen in neurodegenerative disorders such as Parkinson’s disease, in frailty and sarcopenia among older adults, and in gut-related conditions like inflammatory bowel disease and pancreatic cancer. Elevated concentrations, on the other hand, can appear in obesity and diarrhea-predominant irritable bowel syndrome (IBS-D), where absorption is reduced.